Rare disease drug maker BioMarin’s unusual path to campus expansion in Marin: Team up with a local senior center

The rare-disease drug developer and San Rafael nonprofit Whistlestop have set their sights on securing the building approvals necessary to redevelop 999 Third St. into two massive research facilities and a building with an active aging center topped with senior affordable housing.